| Product Code: ETC6751996 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China RNA Targeting Small Molecule Drug Discovery Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 China RNA Targeting Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 China RNA Targeting Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 China RNA Targeting Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development of RNA targeting small molecule drugs in China |
4.2.2 Growing prevalence of complex diseases that require targeted therapies |
4.2.3 Technological advancements in RNA-targeting drug discovery processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for RNA-targeting small molecule drugs |
4.3.2 Limited availability of skilled researchers and scientists in the field of RNA targeting drug discovery in China |
5 China RNA Targeting Small Molecule Drug Discovery Market Trends |
6 China RNA Targeting Small Molecule Drug Discovery Market, By Types |
6.1 China RNA Targeting Small Molecule Drug Discovery Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.4 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.1.6 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.1.7 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China RNA Targeting Small Molecule Drug Discovery Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F |
6.2.3 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.2.4 China RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 China RNA Targeting Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 China RNA Targeting Small Molecule Drug Discovery Market Export to Major Countries |
7.2 China RNA Targeting Small Molecule Drug Discovery Market Imports from Major Countries |
8 China RNA Targeting Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Number of patents filed for RNA-targeting small molecule drugs in China |
8.2 Research and development expenditure allocated towards RNA-targeting drug discovery projects |
8.3 Number of partnerships and collaborations between Chinese pharmaceutical companies and global biotech firms in the RNA targeting space |
9 China RNA Targeting Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 China RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 China RNA Targeting Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 China RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 China RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here